Head and neck cancer (HNC) is the sixth most prevalent cancer worldwide with a poor prognosis when diagnosed at advanced clinical stages. The main risk factors are tobacco consumption and alcohol abuse. The article discusses the use of liquid biopsies as a minimally invasive diagnostic tool for HPV-positive head and neck cancer, as it could improve access to early cancer detection and monitoring.
The World Health Organization reports that cervical cancer ranks as the eighth most common cancer worldwide and is the ninth leading cause of cancer-related deaths. Cervical cancer is a significant global health challenge, with high incidence and mortality rates, especially in sub-Saharan Africa. While immunotherapy has emerged as a promising strategy, its efficacy is variable among patients. Predictive biomarkers are essential for identifying patients most likely to benefit from immunotherapy.
